Karen M Kuntz1, Iris Lansdorp-Vogelaar2, Carolyn M Rutter3, Amy B Knudsen4, Marjolein van Ballegooijen2, James E Savarino3, Eric J Feuer5, Ann G Zauber6. 1. Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis (KMK) 2. Department of Public Health, Erasmus MC, Rotterdam, the Netherlands (IL-V, MvB) 3. Center for Health Studies, Group Health Research Institute, Seattle, Washington (CMR, JES) 4. Institute for Technology Assessment, Massachusetts General Hospital, Boston (ABK) 5. Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland (EJF) 6. Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY (AGZ)
Abstract
BACKGROUND: As the complexity of microsimulation models increases, concerns about model transparency are heightened. METHODS: The authors conducted model "experiments" to explore the impact of variations in "deep" model parameters using 3 colorectal cancer (CRC) models. All natural history models were calibrated to match observed data on adenoma prevalence and cancer incidence but varied in their underlying specification of the adenocarcinoma process. The authors projected CRC incidence among individuals with an underlying adenoma or preclinical cancer v. those without any underlying condition and examined the impact of removing adenomas. They calculated the percentage of simulated CRC cases arising from adenomas that developed within 10 or 20 years prior to cancer diagnosis and estimated dwell time-defined as the time from the development of an adenoma to symptom-detected cancer in the absence of screening among individuals with a CRC diagnosis. RESULTS: The 20-year CRC incidence among 55-year-old individuals with an adenoma or preclinical cancer was 7 to 75 times greater than in the condition-free group. The removal of all adenomas among the subgroup with an underlying adenoma or cancer resulted in a reduction of 30% to 89% in cumulative incidence. Among CRCs diagnosed at age 65 years, the proportion arising from adenomas formed within 10 years ranged between 4% and 67%. The mean dwell time varied from 10.6 to 25.8 years. CONCLUSIONS: Models that all match observed data on adenoma prevalence and cancer incidence can produce quite different dwell times and very different answers with respect to the effectiveness of interventions. When conducting applied analyses to inform policy, using multiple models provides a sensitivity analysis on key (unobserved) "deep" model parameters and can provide guidance about specific areas in need of additional research and validation.
BACKGROUND: As the complexity of microsimulation models increases, concerns about model transparency are heightened. METHODS: The authors conducted model "experiments" to explore the impact of variations in "deep" model parameters using 3 colorectal cancer (CRC) models. All natural history models were calibrated to match observed data on adenoma prevalence and cancer incidence but varied in their underlying specification of the adenocarcinoma process. The authors projected CRC incidence among individuals with an underlying adenoma or preclinical cancer v. those without any underlying condition and examined the impact of removing adenomas. They calculated the percentage of simulated CRC cases arising from adenomas that developed within 10 or 20 years prior to cancer diagnosis and estimated dwell time-defined as the time from the development of an adenoma to symptom-detected cancer in the absence of screening among individuals with a CRC diagnosis. RESULTS: The 20-year CRC incidence among 55-year-old individuals with an adenoma or preclinical cancer was 7 to 75 times greater than in the condition-free group. The removal of all adenomas among the subgroup with an underlying adenoma or cancer resulted in a reduction of 30% to 89% in cumulative incidence. Among CRCs diagnosed at age 65 years, the proportion arising from adenomas formed within 10 years ranged between 4% and 67%. The mean dwell time varied from 10.6 to 25.8 years. CONCLUSIONS: Models that all match observed data on adenoma prevalence and cancer incidence can produce quite different dwell times and very different answers with respect to the effectiveness of interventions. When conducting applied analyses to inform policy, using multiple models provides a sensitivity analysis on key (unobserved) "deep" model parameters and can provide guidance about specific areas in need of additional research and validation.
Authors: J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman Journal: N Engl J Med Date: 2000-11-30 Impact factor: 91.245
Authors: P C Prorok; G L Andriole; R S Bresalier; S S Buys; D Chia; E D Crawford; R Fogel; E P Gelmann; F Gilbert; M A Hasson; R B Hayes; C C Johnson; J S Mandel; A Oberman; B O'Brien; M M Oken; S Rafla; D Reding; W Rutt; J L Weissfeld; L Yokochi; J K Gohagan Journal: Control Clin Trials Date: 2000-12
Authors: Sidney Winawer; Robert Fletcher; Douglas Rex; John Bond; Randall Burt; Joseph Ferrucci; Theodore Ganiats; Theodore Levin; Steven Woolf; David Johnson; Lynne Kirk; Scott Litin; Clifford Simmang Journal: Gastroenterology Date: 2003-02 Impact factor: 22.682
Authors: Marjolein van Ballegooijen; Carolyn M Rutter; Amy B Knudsen; Ann G Zauber; James E Savarino; Iris Lansdorp-Vogelaar; Rob Boer; Eric J Feuer; J Dik F Habbema; Karen M Kuntz Journal: Med Decis Making Date: 2011-06-14 Impact factor: 2.583
Authors: Alex van der Steen; Amy B Knudsen; Frank van Hees; Gailya P Walter; Franklin G Berger; Virginie G Daguise; Karen M Kuntz; Ann G Zauber; Marjolein van Ballegooijen; Iris Lansdorp-Vogelaar Journal: Health Serv Res Date: 2014-10-16 Impact factor: 3.402
Authors: Thomas F Imperiale; Menggang Yu; Patrick O Monahan; Timothy E Stump; Rebeka Tabbey; Elizabeth Glowinski; David F Ransohoff Journal: J Natl Cancer Inst Date: 2016-08-31 Impact factor: 13.506
Authors: Diana L Lam; Pari V Pandharipande; Janie M Lee; Constance D Lehman; Christoph I Lee Journal: AJR Am J Roentgenol Date: 2014-11 Impact factor: 3.959
Authors: Rafael Meza; Kevin ten Haaf; Chung Yin Kong; Ayca Erdogan; William C Black; Martin C Tammemagi; Sung Eun Choi; Jihyoun Jeon; Summer S Han; Vidit Munshi; Joost van Rosmalen; Paul Pinsky; Pamela M McMahon; Harry J de Koning; Eric J Feuer; William D Hazelton; Sylvia K Plevritis Journal: Cancer Date: 2014-02-27 Impact factor: 6.860
Authors: Audrey H Calderwood; John A Baron; Leila A Mott; Dennis J Ahnen; Roberd M Bostick; Jane C Figueiredo; Michael N Passarelli; Judy R Rees; Douglas J Robertson; Elizabeth L Barry Journal: Cancer Prev Res (Phila) Date: 2019-03-04
Authors: Carolyn M Rutter; Amy B Knudsen; Tracey L Marsh; V Paul Doria-Rose; Eric Johnson; Chester Pabiniak; Karen M Kuntz; Marjolein van Ballegooijen; Ann G Zauber; Iris Lansdorp-Vogelaar Journal: Med Decis Making Date: 2016-01-08 Impact factor: 2.583